261 related articles for article (PubMed ID: 29543631)
1. Amisulpride Prevents Postoperative Nausea and Vomiting in Patients at High Risk: A Randomized, Double-blind, Placebo-controlled Trial.
Kranke P; Bergese SD; Minkowitz HS; Melson TI; Leiman DG; Candiotti KA; Liu N; Eberhart L; Habib AS; Wallenborn J; Kovac AL; Diemunsch P; Fox G; Gan TJ
Anesthesiology; 2018 Jun; 128(6):1099-1106. PubMed ID: 29543631
[TBL] [Abstract][Full Text] [Related]
2. Amisulpride for the Rescue Treatment of Postoperative Nausea or Vomiting in Patients Failing Prophylaxis: A Randomized, Placebo-controlled Phase III Trial.
Habib AS; Kranke P; Bergese SD; Chung F; Ayad S; Siddiqui N; Motsch J; Leiman DG; Melson TI; Diemunsch P; Fox GM; Candiotti KA
Anesthesiology; 2019 Feb; 130(2):203-212. PubMed ID: 30475232
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Amisulpride for the Prevention of Postoperative Nausea and Vomiting: Two Concurrent, Randomized, Double-blind, Placebo-controlled Trials.
Gan TJ; Kranke P; Minkowitz HS; Bergese SD; Motsch J; Eberhart L; Leiman DG; Melson TI; Chassard D; Kovac AL; Candiotti KA; Fox G; Diemunsch P
Anesthesiology; 2017 Feb; 126(2):268-275. PubMed ID: 27902493
[TBL] [Abstract][Full Text] [Related]
4. I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial.
Kranke P; Eberhart L; Motsch J; Chassard D; Wallenborn J; Diemunsch P; Liu N; Keh D; Bouaziz H; Bergis M; Fox G; Gan TJ
Br J Anaesth; 2013 Dec; 111(6):938-45. PubMed ID: 23872464
[TBL] [Abstract][Full Text] [Related]
5. Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Amisulpride as Treatment of Established Postoperative Nausea and Vomiting in Patients Who Have Had No Prior Prophylaxis.
Candiotti KA; Kranke P; Bergese SD; Melson TI; Motsch J; Siddiqui N; Chung F; Rodriguez Y; Minkowitz HS; Ayad SS; Diemunsch P; Fox G
Anesth Analg; 2019 Jun; 128(6):1098-1105. PubMed ID: 31094774
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting.
Fox GM; Albayaty M; Walker JL; Xue H; Darpo B
Anesth Analg; 2021 Jan; 132(1):150-159. PubMed ID: 31913911
[TBL] [Abstract][Full Text] [Related]
7. Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial.
Herrstedt J; Summers Y; Jordan K; von Pawel J; Jakobsen AH; Ewertz M; Chan S; Naik JD; Karthaus M; Dubey S; Davis R; Fox GM
Support Care Cancer; 2019 Jul; 27(7):2699-2705. PubMed ID: 30488222
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
[TBL] [Abstract][Full Text] [Related]
9. Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: A randomised double-blind placebo-controlled study.
Bataille A; Letourneulx JF; Charmeau A; Lemedioni P; Léger P; Chazot T; Le Guen M; Diemunsch P; Fischler M; Liu N
Eur J Anaesthesiol; 2016 Dec; 33(12):898-905. PubMed ID: 26866433
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
[TBL] [Abstract][Full Text] [Related]
11. Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trial.
Ryu JH; Jeon YT; Hwang JW; Oh AY; Moon JY; Ro YJ; Kim CS; Chen C; Apfel CC; Do SH
Clin Ther; 2011 Sep; 33(9):1162-72. PubMed ID: 21856001
[TBL] [Abstract][Full Text] [Related]
12. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
[TBL] [Abstract][Full Text] [Related]
13. Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study.
Dewinter G; Teunkens A; Vermeulen K; Devroe S; Van Hemelrijck J; Meuleman C; Vergote I; Fieuws S; Van de Velde M; Rex S
Eur J Anaesthesiol; 2016 Feb; 33(2):96-103. PubMed ID: 26086285
[TBL] [Abstract][Full Text] [Related]
14. Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures.
Gesztesi Z; Scuderi PE; White PF; Wright W; Wender RH; D'Angelo R; Black LS; Dalby PL; MacLean D
Anesthesiology; 2000 Oct; 93(4):931-7. PubMed ID: 11020741
[TBL] [Abstract][Full Text] [Related]
15. The effects of intravenous fosaprepitant and ondansetron in the prevention of postoperative nausea and vomiting in patients who underwent lower limb surgery: a prospective, randomized, double-blind study.
Kakuta N; Kume K; Hamaguchi E; Tsutsumi R; Mita N; Tanaka K; Tsutsumi YM
J Anesth; 2015 Dec; 29(6):836-41. PubMed ID: 26210166
[TBL] [Abstract][Full Text] [Related]
16. Aprepitant for antiemesis after laparoscopic gynaecological surgery: A randomised controlled trial.
Ham SY; Shim YH; Kim EH; Son MJ; Park WS; Lee JS
Eur J Anaesthesiol; 2016 Feb; 33(2):90-5. PubMed ID: 26694939
[TBL] [Abstract][Full Text] [Related]
17. An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting.
Smyla N; Koch T; Eberhart LH; Gehling M
Expert Opin Pharmacother; 2020 Apr; 21(5):517-522. PubMed ID: 31971450
[No Abstract] [Full Text] [Related]
18. Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled study.
Pandey CK; Priye S; Ambesh SP; Singh S; Singh U; Singh PK
J Postgrad Med; 2006; 52(2):97-100. PubMed ID: 16679671
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
Fabling JM; Gan TJ; El-Moalem HE; Warner DS; Borel CO
Anesth Analg; 2000 Aug; 91(2):358-61. PubMed ID: 10910848
[TBL] [Abstract][Full Text] [Related]
20. Effects of palonosetron for prophylaxis of postoperative nausea and vomiting in high-risk patients undergoing total knee arthroplasty: A prospective, randomized, double-blind, placebo-controlled study.
Ryu JH; Jeon YT; Min B; Hwang JY; Sohn HM
PLoS One; 2018; 13(5):e0196388. PubMed ID: 29758039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
